PerkinElmer, Inc. (NYSE:PKI) insider Andrew Okun sold 12,680 shares of the company’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $72.00, for a total value of $912,960.00. Following the completion of the transaction, the insider now owns 25,121 shares of the company’s stock, valued at $1,808,712. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

PerkinElmer, Inc. (NYSE:PKI) opened at $73.84 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59. PerkinElmer, Inc. has a 12 month low of $50.59 and a 12 month high of $74.12. The stock has a market capitalization of $7,950.54, a price-to-earnings ratio of 25.95, a price-to-earnings-growth ratio of 2.16 and a beta of 0.77.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, January 18th. This represents a $0.28 annualized dividend and a yield of 0.38%. PerkinElmer’s dividend payout ratio is currently 7.78%.

PKI has been the subject of a number of recent research reports. Robert W. Baird upped their target price on PerkinElmer from $75.00 to $78.00 and gave the company an “outperform” rating in a research note on Friday, November 3rd. Morgan Stanley restated an “overweight” rating and issued a $77.00 target price (down from $79.00) on shares of PerkinElmer in a research note on Friday, October 6th. Jefferies Group restated a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a research note on Friday, October 20th. Cowen restated a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a research note on Friday, September 1st. Finally, ValuEngine lowered PerkinElmer from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company. PerkinElmer currently has a consensus rating of “Hold” and a consensus price target of $70.79.

A number of institutional investors have recently added to or reduced their stakes in PKI. Retirement Systems of Alabama grew its holdings in shares of PerkinElmer by 0.5% during the second quarter. Retirement Systems of Alabama now owns 53,352 shares of the medical research company’s stock worth $3,635,000 after purchasing an additional 284 shares during the last quarter. TD Asset Management Inc. grew its holdings in shares of PerkinElmer by 1.2% during the second quarter. TD Asset Management Inc. now owns 44,126 shares of the medical research company’s stock worth $3,007,000 after purchasing an additional 520 shares during the last quarter. Schwab Charles Investment Management Inc. grew its holdings in shares of PerkinElmer by 6.2% during the second quarter. Schwab Charles Investment Management Inc. now owns 594,337 shares of the medical research company’s stock worth $40,499,000 after purchasing an additional 34,680 shares during the last quarter. Arizona State Retirement System grew its holdings in shares of PerkinElmer by 0.4% during the second quarter. Arizona State Retirement System now owns 27,277 shares of the medical research company’s stock worth $1,859,000 after purchasing an additional 100 shares during the last quarter. Finally, Teacher Retirement System of Texas grew its holdings in shares of PerkinElmer by 1.1% during the second quarter. Teacher Retirement System of Texas now owns 8,779 shares of the medical research company’s stock worth $598,000 after purchasing an additional 94 shares during the last quarter. Hedge funds and other institutional investors own 91.37% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Andrew Okun Sells 12,680 Shares of PerkinElmer, Inc. (PKI) Stock” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/andrew-okun-sells-12680-shares-of-perkinelmer-inc-pki-stock/1773997.html.

About PerkinElmer

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.